Ledger.Open graph →
SEC Form D · filed June 26, 2024

Eumentis Therapeutics, Inc

Offering
$2.0M
Sold
$765K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Randall Marshall · Newton, MAExecKim Patrick · Newton, MADirectorJames Larrick · Newton, MADirectorMaryann Bryla · Newton, MADirectorMark Tepper · Newton, MAExec · DirectorAndrew Pearlman · Newton, MADirectorCarsten D. Koppen · St Helier, Y9Exec · DirectorThomas Roeder · Nantucket, MADirectorMats N. Eklund · St Helier, Y9DirectorMichael Baran · San Diego, CADirectorAdrian Bot · San Diego, CAExecIlon R. Wu · New York, NYDirectorSteve B. Kim · San Mateo, CADirectorS. C. Honig · San Mateo, CAExec · DirectorRobby Peters · San Mateo, CADirectorAndrew E. Braithwaite · Salt Lake City, UTExecSophia Dilbert · Grand Cayman, Cayman IslandsDirectorClaude Radoux · Grand Duchy of Luxembourg, LuxembourgDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗